This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hansen, T. K. Articles by Poulsen, P. L. Search for Related Content PubMed PubMed Citation Articles by Hansen, T. K. Articles by Poulsen, P. L. Pubmed/NCBI databases Gene Compound via MeSH Substance via MeSH Medline Plus Health Information Diabetes Type 1

Elevated Levels of Mannan-Binding Lectin in Patients with Type 1 Diabetes

Medical Department M (T.K.H., S.T.K., C.H.G., J.S.C., C.E.M., P.L.P.), Aarhus University Hospital, and Department of Medical Microbiology and Immunology (S.T.), Aarhus University, DK-8000 Aarhus, Denmark

Address all correspondence and requests for reprints to: Troels Krarup Hansen, M.D., Ph.D., Medical Department M (Endocrinology and Diabetes), Aarhus University Hospital, Norrebrogade 42-44, DK-8000 Aarhus C, Denmark. E-mail: tkh{at}dadlnet.dk.

The hepatic protein mannan-binding lectin (MBL) activates the complement system on binding to carbohydrate patterns and is involved in first-line defense against invading microorganisms. Emerging evidence indicates that in some situations MBL may cause inexpedient complement activation and tissue injury through binding to endothelial glycosylations. MBL levels are suppressed by insulin treatment in critically ill patients, and, hypothetically, hepatic portal hypoinsulinemia could lead to increased levels of MBL in patients with type 1 diabetes. We measured MBL and C-reactive protein (CRP) levels in 132 normoalbuminuric type 1 diabetic patients and 66 healthy age- and sex-matched controls. The median MBL concentration was higher in diabetic patients than in healthy controls [1290 µg/liter (interquartile range, IQR 354-2961 µg/liter) vs. 970 µg/liter (IQR 277-1607 µg/liter), P = 0.025], whereas CRP concentrations were similar among patients and controls [1.42 mg/liter (IQR 0.95–2.21) vs. 1.21 mg/l (IQR 0.74–2.13), NS]. In diabetic subjects, CRP levels correlated with poor glycemic control as indicated by hemoglobin A_1c and daily insulin dose, which was not the case with MBL. MBL concentrations were positively correlated with urinary albumin excretion (r = 0.22; P = 0.013) and increased with increasing urinary albumin excretion tertile (P = 0.036). In conclusion, our data demonstrate that circulating MBL concentrations are significantly elevated in patients with type 1 diabetes and suggest a possible role of MBL in the pathogenesis of renovascular complications in diabetes.

Abbreviations: CRP, C-reactive protein; Hb, hemoglobin; IQR, interquartile range; MBL, mannan-binding lectin; UAE, urinary albumin excretion.

This article has been cited by other articles:

				M. A. Kaunisto, L. Sjolind, R. Sallinen, K. Pettersson-Fernholm, M. Saraheimo, S. Frojdo, C. Forsblom, J. Fagerudd, T. K. Hansen, A. Flyvbjerg, et al. Elevated MBL Concentrations Are Not an Indication of Association Between the MBL2 Gene and Type 1 Diabetes or Diabetic Nephropathy Diabetes, July 1, 2009; 58(7): 1710 - 1714. [Abstract] [Full Text] [PDF]

				T. B. Rasmussen, S. Dalager, N. H. Andersen, T. K. Hansen, and J. E. Nielsen-Kudsk Fatal giant cell myocarditis in a patient with multiple autoimmune disorders BMJ Case Reports, April 28, 2009; 2009(apr23_1): bcr0920080997 - bcr0920080997. [Abstract] [Full Text]

				A. Roos, M. R. Daha, J. van Pelt, and S. P. Berger Mannose-binding lectin and the kidney Nephrol. Dial. Transplant., December 1, 2007; 22(12): 3370 - 3377. [Full Text] [PDF]

				T. K. Hansen, M.-A. Gall, L. Tarnow, S. Thiel, C. D. Stehouwer, C. G. Schalkwijk, H.-H. Parving, and A. Flyvbjerg Mannose-binding lectin and mortality in type 2 diabetes. Arch Intern Med, October 9, 2006; 166(18): 2007 - 2013. [Abstract] [Full Text] [PDF]

				L. H. Bouwman, P. Eerligh, O. T. Terpstra, M. R. Daha, P. de Knijff, B. E.P.B. Ballieux, G. J. Bruining, A. R. van der Slik, A. Roos, and B. O. Roep Elevated Levels of Mannose-Binding Lectin at Clinical Manifestation of Type 1 Diabetes in Juveniles Diabetes, October 1, 2005; 54(10): 3002 - 3006. [Abstract] [Full Text] [PDF]

				D. A. Schaumberg, R. J. Glynn, A. J. Jenkins, T. J. Lyons, N. Rifai, J. E. Manson, P. M. Ridker, and D. M. Nathan Effect of Intensive Glycemic Control on Levels of Markers of Inflammation in Type 1 Diabetes Mellitus in the Diabetes Control and Complications Trial Circulation, May 17, 2005; 111(19): 2446 - 2453. [Abstract] [Full Text] [PDF]

				P. Hovind, T. K. Hansen, L. Tarnow, S. Thiel, R. Steffensen, A. Flyvbjerg, and H.-H. Parving Mannose-Binding Lectin as a Predictor of Microalbuminuria in Type 1 Diabetes: An Inception Cohort Study Diabetes, May 1, 2005; 54(5): 1523 - 1527. [Abstract] [Full Text] [PDF]

				T. K. Hansen, L. Tarnow, S. Thiel, R. Steffensen, C. D. Stehouwer, C. G. Schalkwijk, H.-H. Parving, and A. Flyvbjerg Association Between Mannose-Binding Lectin and Vascular Complications in Type 1 Diabetes Diabetes, June 1, 2004; 53(6): 1570 - 1576. [Abstract] [Full Text] [PDF]